Malherbe P, Draguhn A, Multhaup G, Beyreuther K, Möhler H
Research Department, F. Hoffmann-La Roche, Basel, Switzerland.
Brain Res Mol Brain Res. 1990 Aug;8(3):199-208. doi: 10.1016/0169-328x(90)90017-8.
In mammalian brain, the activation of GABAA-receptors is associated with the opening of chloride channels, whose function can be allosterically modulated by drugs, in particular by ligands of the benzodiazepine receptor. Agonistic ligands potentiate while inverse agonists reduce the efficiency of GABA. We have cloned cDNAs encoding alpha 1- and beta 1-subunits of the GABAA-receptor from rat brain. When the corresponding RNAs were co-expressed in Xenopus oocytes. GABA-induced currents were recorded which were inhibited by bicuculline and potentiated by pentobarbital. GABA activated the channel in a weakly cooperative manner. Furthermore, the GABA-response was modulated by benzodiazepine receptor ligands. However, not only various agonists but also the antagonist flumazenil and the inverse agonist DMCM potentiated the GABA-response. Thus, alpha 1- and beta 1-subunits are sufficient to form GABAA-receptors which contain benzodiazepine binding sites, although in a functionally restricted form.
在哺乳动物大脑中,GABAA受体的激活与氯离子通道的开放相关,其功能可被药物变构调节,尤其是苯二氮䓬受体的配体。激动剂配体增强GABA的作用,而反向激动剂则降低GABA的效率。我们从大鼠脑中克隆了编码GABAA受体α1和β1亚基的cDNA。当相应的RNA在非洲爪蟾卵母细胞中共同表达时,记录到了GABA诱导的电流,该电流被荷包牡丹碱抑制,并被戊巴比妥增强。GABA以弱协同方式激活通道。此外,GABA反应受苯二氮䓬受体配体调节。然而,不仅各种激动剂,而且拮抗剂氟马西尼和反向激动剂DMCM都增强了GABA反应。因此,α1和β1亚基足以形成含有苯二氮䓬结合位点的GABAA受体,尽管其功能形式有限。